إعلان
إعلان

FBIO

FBIO logo

Fortress Biotech, Inc.

4.32
USD
برعاية
-0.06
-1.46%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

4.40

+0.08
+1.95%

تقارير أرباح FBIO

النسبة الإيجابية المفاجئة

FBIO تفوق 23 من 39 آخر التقديرات.

59%

التقرير التالي

بيانات التقرير القادم
٢٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$23.61M
/
-$0.35
التغير الضمني من Q3 25 (Revenue/ EPS)
+33.90%
/
-418.18%
التغير الضمني من Q4 24 (Revenue/ EPS)
+56.14%
/
-53.33%

Fortress Biotech, Inc. earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, FBIO reported earnings of 0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 125.68% surprise. Revenue reached 17.63 مليون, compared to an expected 21.44 مليون, with a -17.76% difference. The market reacted with a +5.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.35 USD, with revenue projected to reach 23.61 مليون USD, implying an نقصان of -418.18% EPS, and زيادة of 33.90% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Fortress Biotech, Inc. reported EPS of $0.11, beating estimates by 125.68%, and revenue of $17.63M, -17.76% below expectations.
The stock price moved up 5.22%, changed from $2.49 before the earnings release to $2.62 the day after.
The next earning report is scheduled for ٢٤ مارس ٢٠٢٦.
Based on 4 المحللين, Fortress Biotech, Inc. is expected to report EPS of -$0.35 and revenue of $23.61M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان